<DOC>
	<DOCNO>NCT01939184</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy various fix daily dos WC3055 compare placebo treatment subject LUTS secondary BPH .</brief_summary>
	<brief_title>Assess Safety &amp; Efficacy WC3055 Men With Lower Urinary Tract Symptoms Secondary Benign Prostatic Hyperplasia</brief_title>
	<detailed_description />
	<mesh_term>Hyperplasia</mesh_term>
	<mesh_term>Prostatic Hyperplasia</mesh_term>
	<mesh_term>Lower Urinary Tract Symptoms</mesh_term>
	<criteria>History LUTS ≥6 month secondary BPH Total IPSS ( International Prostate Symptom Score ) ≥ 13 Screening</criteria>
	<gender>Male</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>